Seal, Stopping Eczema and Allergy Study | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Seal, Stopping Eczema and Allergy Study	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eczema, Infantile, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, food allergy, hereditary disease, hereditary skin disorder, immune system disorder, skin disorder	Active, not recruiting	Phase 2	2026-02-27		NCT03742414

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Children's Hospital Medical Center, Cincinnati	229
Guy's and St Thomas' NHS Foundation Trust	118
Harvard School of Public Health (HSPH)	46
Kari Nadeau, MD, PhD	1
King's College London	203
National Institute of Allergy and Infectious Diseases (NIAID)	402
National Jewish Health	31
Stanford University	620
University of Chicago	326

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cincinnati Children's Hospital Medical Center	Cincinnati	United States	405
Division of Pediatric Allergy and Clinical Immunology, National Jewish Health	Denver	United States	1
Sean N. Parker Center for Allergy & Asthma Research at Stanford University	Palo Alto	United States	1
University of Chicago	Chicago	United States	312
• King's College London and Guy's and St. Thomas' NHS Foundation Trust, UK	London	United Kingdom	1